Investigating the effects of ebselen, a potential new lithium mimetic, on glutamate transmission.
Mota F., Sementa T., Taddei C., Moses N., Bordoloi J., Hader S., Eykyn T., Cash D., Turkheimer F., Veronese M., Singh N.
Ebselen, a potential new lithium-like drug, treatment reduced brain glutamate, as measured by PET imaging using the mGluR5 radioligand [18 F]FPEB in rats.